Search
To assess relationships between continuous glucose monitoring (CGM) time in range (TIR), 70-180 mg/dL, time below range (TBR), <70 mg/dL, time above range (TAR), >180 mg/dL, and glucose coefficient of variation (CV) in relation to currently recommended clinical CGM targets for older people, which recommend reduced TIR and TBR targets relative to the general type 1 diabetes population.
Tim Jones MBBS DCH FRACP MD Co-head, Diabetes and Obesity Research Co-head, Diabetes and Obesity Research Areas of research expertise: Diabetes
To determine the efficacy of advanced hybrid closed-loop therapy in a high-risk cohort of youth on continuous subcutaneous insulin infusion with or without continuous glucose monitoring with suboptimal glycemia.
To explore parents' experiences of using continuous glucose monitoring in their young children with early-stage type 1 diabetes, being followed in the Australian Environmental Determinants of Islet Autoimmunity (ENDIA) study.
Less than 20% of Australians with type 1 diabetes (T1D) meet recommended glucose targets. Technology use is associated with better glycaemia, with the most advanced being automated insulin delivery (AID) systems, which are now recommended as gold-standard T1D care. Our Australian AID trial shows a wide spectrum of adults with T1D can achieve recommended targets. Other studies, including lived experience data, are supportive. Insulin pumps are not subsidised for most Australian adults with T1D. We advocate change.
The Children’s Diabetes Centre’s (CDC) annual workshop provided a great opportunity for diabetes researchers to get together in the one venue to showcase their work recently.
Insulin pump company Ypsomed Australia has announced an offer for families currently using an Animas Vibe.
Meet Charlotta Swenson Backelin and Louise Haggendal. The medical students, from the University of Gothenburg in Sweden, have spent the past two months helping the The Kids’ Children’s Diabetes Centre conduct exercise research as part of their degrees.
Oliver Bowman is too young to understand the enormity of having type 1 diabetes but his young parents Brooke and Aidan know all too well the reality of having a child with a chronic disease.
Seventeen-year-old Andrew says he has a better handle on managing his type 1 diabetes since taking part in an at-home research trial involving a sophisticated new pump system. Watch Andrew, his mum Leeanne and The Kids researcher Professor Tim Jones discuss the trial on Today Tonight.